The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGRA.L Regulatory News (GRA)

  • There is currently no data for GRA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 Jan 2018 07:00

RNS Number : 5906C
Grafenia plc
23 January 2018
 

Grafenia plc

(the "Group" or "Grafenia")

Board Appointments

 

The Group is pleased to announce that Gavin Cockerill and Richard Lightfoot have been appointed to the Board as Executive Directors with effect from 23 January 2018.

 

Gavin joined the Group in 2000 and helped launch and grow the printing.com and Nettl business models. In October 2015 he was appointed COO and he is responsible for sales processes and business development across all Grafenia businesses.

Richard has been with Grafenia since 2004, in different roles with increasing responsibility, and played a key role in sourcing and executing the recent sign business acquisitions. He was appointed Company Secretary in October 2015.

Commenting on the appointment, Jan Mohr, Chairman of the Group said: "We are delighted to announce the promotion of Gavin and Richard to the PLC Board. Both have been key team members for many years and have contributed tremendously to the recent strategic repositioning of Grafenia. They are role-models for our entire organisation and we are looking forward to seeing them excel with their wider responsibilities."

 

The following disclosures are made pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies:

 

Richard Alan Lightfoot (aged 45) is interested in 75,000 ordinary shares in the Group, representing approximately 0.2 per cent. of the current issued share capital of the Group.

 

Gavin Graham Cockerill (aged 39) is interested in 4,874 ordinary shares in the Group, representing approximately 0.01 per cent. of the current issued share capital of the Group.

 

There is no further information to be disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

 

 

 

For further information:

Grafenia plc

Jan Mohr (Chairman)

 

0049 175 734 2740

N+1 Singer (Nominated Adviser)

Richard Lindley / James White

020 7496 3000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABTMPTMBMTBPP
Date   Source Headline
17th Oct 20237:00 amRNSChange of Company name effective
16th Oct 20236:30 pmRNSDirector/PDMR Shareholding
6th Oct 20239:37 amRNSGrant of options
26th Sep 202312:21 pmRNSResult of AGM and Change of Name and Website
21st Sep 20237:00 amRNSHolding(s) in Company
20th Sep 20235:39 pmRNSHolding(s) in Company
15th Sep 20235:47 pmRNSReplacement: Result of GM and Open Offer
15th Sep 202310:22 amRNSResult of General Meeting and Open Offer
8th Sep 20232:03 pmRNSDirector/PDMR Shareholding
29th Aug 20237:00 amRNSFundraise of up to £27.9 million and other matters
26th Jul 20237:00 amRNSFinal Results
1st Jun 20237:00 amRNSUpdate re. the sale of Works Manchester Limited
3rd May 20237:00 amRNSPre-close statement and Trading Update
3rd Apr 20231:13 pmRNSHolding(s) in Company
17th Feb 202312:35 pmRNSAcquisition of Topfloor Systems Limited
20th Jan 20232:49 pmRNSBond Issue
18th Jan 20237:00 amRNSAcquisition of Care Management Systems Limited
28th Dec 20227:00 amRNSHolding(s) in Company
13th Dec 20227:00 amRNSReplacement: Bond Issue
12th Dec 20225:51 pmRNSBond Issue
7th Dec 20225:07 pmRNSAcquisition of Watermark Technologies Limited
24th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSBoard Appointment
7th Oct 202211:37 amRNSHolding(s) in Company
6th Oct 20221:48 pmRNSHolding(s) in Company
27th Sep 202212:56 pmRNSBond Issue
22nd Sep 20224:09 pmRNSAcquisition of Vertical Plus Limited
14th Sep 20222:18 pmRNSResult of AGM
27th Jul 20223:18 pmRNSReplacement: Final Results
27th Jul 20227:00 amRNSFinal Results
19th May 20227:00 amRNSSale of Subsidiary and Board Changes
4th May 20229:01 amRNSDirector/PDMR Shareholding
6th Apr 202212:00 pmRNSPre-close statement and Trading Update
22nd Nov 20217:00 amRNSHalf-year Report
15th Sep 202110:35 amRNSResult of AGM
15th Sep 20217:00 amRNSAGM Trading Statement
28th Jul 20217:00 amRNSFinal Results
16th Apr 20217:00 amRNSPre-close Trading and Strategy Update
3rd Mar 20217:00 amRNSBlock admission review & block cancellation
8th Jan 202112:38 pmRNSStmnt re Share Price Movement
31st Dec 20201:00 pmRNSTotal Voting Rights
14th Dec 20203:45 pmRNSIssue of Equity re Share Stake Scheme
25th Nov 20207:00 amRNSHalf-year Report
22nd Sep 202011:31 amRNSResult of AGM
22nd Sep 20207:00 amRNSAGM Trading Statement and Acquisition Update
3rd Sep 20207:00 amRNSBlock listing Interim Review
1st Sep 20207:00 amRNSReplacement: Final Results
12th Aug 20207:00 amRNSFinal Results
24th Jul 202012:37 pmRNSReplacement: Bond Facility & trading update
15th Jul 202010:45 amRNSBond Facility for up to £50m & trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.